Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
jRCT1011200008 in the Japan Registry of Clinical Trials (jRCT)
Generic semaglutide injectables will be 6080% cheaper than current Ozempic-branded pricing (~USD 997 per pen) India-manufactured GLP-1 injectables will be the primary supply source for Asia, Africa, Middle East, and LATAM Type-2 diabetes segment (72% of 2026 demand) and the obesity segment (fastest CAGR) both sustain long-run volume Pipeline indications NASH, cardiovascular, early Alzheimers, pediatric obesity will expand addressable patient segments beyond 2026 Counterfeit semaglutide is a documented 20252026 market risk
So here we have an approved cosmetic surgeon, buying a generic unapproved drug from China for ten bucks a vial (rough estimate) and then selling a prescribed medicinal dosage as a service, and injecting it into their patients for an insane markup
(2010) Global prevalence of chronic migraine: a systematic review
US$ 20.36
US$ 22.89
US$ 24.38
